Adenosine A2B receptor-mediated leukemia inhibitory factor release from astrocytes protects cortical neurons against excitotoxicity

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Moidunny, Shamsudheen ^a   Vinet, Jonathan ^a   Wesseling, Evelyn ^a   Bijzet, Johan ^a   Shieh, Chu Hsin ^b   van Ijzendoorn, Sven C D ^a   Bezzi, Paola ^c   Boddeke, Hendrikus W G M ^a   Biber, Knut ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

5 N Ethylcarboxamide (NECA); Glutamate; Leukemia inhibitory factor; Neuroprotection

Indexed keywords

ADENOSINE A2B RECEPTOR; CHROMOGRANIN A; CHROMOGRANIN B; CLATHRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; PROTEIN PHOGRIN; RAB11 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR AFFECTING AGENT; GLUTAMIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; EMBRYO; EXCITOTOXICITY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; INTRACELLULAR SIGNALING; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; ANIMAL; BRAIN CORTEX; C57BL MOUSE; CELL CULTURE; METABOLISM; MOUSE MUTANT; NERVE CELL; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; EXCITATORY AMINO ACID AGENTS; GLUTAMIC ACID; LEUKEMIA INHIBITORY FACTOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTOR, ADENOSINE A2B;

EID: 84864922079     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-198     Document Type: Article

References (87)

1. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003, 374:1-20. 10.1042/BJ20030407, 1223585, 12773095.
2. Patterson PH. The emerging neuropoietic cytokine family: first CDF/LIF, CNTF and IL-6; next ONC, MGF, GCSF?. Curr Opin Neurobiol 1992, 2:94-97. 10.1016/0959-4388(92)90169-L, 1386269.
3. Patterson PH. Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology. Proc Natl Acad Sci USA 1994, 91:7833-7835. 10.1073/pnas.91.17.7833, 44497, 8058719.
4. Kurek JB, Bower JJ, Romanella M, Koentgen F, Murphy M, Austin L. The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve 1997, 20:815-822. 10.1002/(SICI)1097-4598(199707)20:7<815::AID-MUS5>3.0.CO;2-A, 9179153.
5. Kwon YW, Abbondanzo SJ, Stewart CL, Gurney ME. Leukemia inhibitory factor influences the timing of programmed synapses withdrawal from neonatal muscles. J Neurobiol 1995, 28:35-50. 10.1002/neu.480280105, 8586964.
6. Akita S, Webster J, Ren SG, Takino H, Said J, Zand O, Melmed S. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest 1995, 95:1288-1298. 10.1172/JCI117779, 441468, 7883977.
7. Chesnokova V, Auernhammer CJ, Melmed S. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology 1998, 139:2209-2216. 10.1210/en.139.5.2209, 9564824.
8. Li M, Sendtner M, Smith A. Essential function of LIF receptor in motor neurons. Nature 1995, 378:724-727. 10.1038/378724a0, 7501019.
9. Murphy M, Reid K, Hilton DJ, Bartlett PF. Generation of sensory neurons is stimulated by leukemia inhibitory factor. Proc Natl Acad Sci USA 1991, 88:3498-3501. 10.1073/pnas.88.8.3498, 51475, 1901659.
10. Mayer M, Bhakoo K, Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994, 120:143-153.
11. Bugga L, Gadient RA, Kwan K, Stewart CL, Patterson PH. Analysis of neuronal and glial phenotypes in brains of mice deficient in leukemia inhibitory factor. J Neurobiol 1998, 36:509-524. 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#, 9740023.
12. Leibinger M, Muller A, Andreadaki A, Hauk TG, Kirsch M, Fischer D. Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukemia inhibitory factor. J Neurosci 2009, 29:14334-14341. 10.1523/JNEUROSCI.2770-09.2009, 19906980.
13. Moidunny S, Dias RB, Wesseling E, Sekino Y, Boddeke HW, Sebastiao AM, Biber K. Interleukin-6-type cytokines in neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A1 receptor function. J Neurochem 2010, 114:1667-1677. 10.1111/j.1471-4159.2010.06881.x, 20598020.
14. Ueki Y, Wang J, Chollangi S, Ash JD. STAT3 activation in photoreceptors by leukemia inhibitory factor is associated with protection from light damage. J Neurochem 2008, 105:784-796. 10.1111/j.1471-4159.2007.05180.x, 18088375.
15. Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118:283-295.
16. Butzkueven H, Zhang JG, Soilu-Hanninen M, Hochrein H, Chionh F, Shipham KA, Emery B, Turnley AM, Petratos S, Ernst M, Bartlett PF, Kilpatrick TJ. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 2002, 8:613-619. 10.1038/nm0602-613, 12042813.
17. Slaets H, Hendriks JJ, Stinissen P, Kilpatrick TJ, Hellings N. Therapeutic potential of LIF in multiple sclerosis. Trends Mol Med 2010, 16:493-500. 10.1016/j.molmed.2010.08.007, 20870461.
18. Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD. Astrocytes promote myelination in response to electrical impulses. Neuron 2006, 49:823-832. 10.1016/j.neuron.2006.02.006, 1474838, 16543131.
19. Murphy GM, Song Y, Ong E, Lee YL, Schmidt KG, Bocchini V, Eng LF. Leukemia inhibitory factor mRNA is expressed in cortical astrocyte cultures but not in an immortalized microglial cell line. Neurosci Lett 1995, 184:48-51. 10.1016/0304-3940(94)11165-F, 7739804.
20. Slevin M, Krupinski J, Mitsios N, Perikleous C, Cuadrado E, Montaner J, Sanfeliu C, Luque A, Kumar S, Kumar P, Gaffney J. Leukaemia inhibitory factor is over-expressed by ischaemic brain tissue concomitant with reduced plasma expression following acute stroke. Eur J Neurol 2008, 15:29-37.
21. Suzuki S, Tanaka K, Nogawa S, Ito D, Dembo T, Kosakai A, Fukuuchi Y. Immunohistochemical detection of leukemia inhibitory factor after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2000, 20:661-668.
22. Mashayekhi F, Salehi Z. Expression of leukemia inhibitory factor in the cerebrospinal fluid of patients with multiple sclerosis. J Clin Neurosci 2011, 18:951-954. 10.1016/j.jocn.2010.12.031, 21570299.
23. Soilu-Hanninen M, Broberg E, Roytta M, Mattila P, Rinne J, Hukkanen V. Expression of LIF and LIF receptor beta in Alzheimer's and Parkinson's diseases. Acta Neurol Scand 2010, 121:44-50. 10.1111/j.1600-0404.2009.01179.x, 20074285.
24. Banner LR, Moayeri NN, Patterson PH. Leukemia inhibitory factor is expressed in astrocytes following cortical brain injury. Exp Neurol 1997, 147:1-9. 10.1006/exnr.1997.6536, 9294397.
25. Yamakuni H, Kawaguchi N, Ohtani Y, Nakamura J, Katayama T, Nakagawa T, Minami M, Satoh M. ATP induces leukemia inhibitory factor mRNA in cultured rat astrocytes. J Neuroimmunol 2002, 129:43-50. 10.1016/S0165-5728(02)00179-0, 12161019.
26. Cunha RA, Vizi ES, Ribeiro JA, Sebastiao AM. Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem 1996, 67:2180-2187.
27. Mitchell JB, Lupica CR, Dunwiddie TV. Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J Neurosci 1993, 13:3439-3447.
28. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 2000, 362:299-309. 10.1007/s002100000309, 11111825.
29. Berman RF, Fredholm BB, Aden U, O'Connor WT. Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats. Brain Res 2000, 872:44-53. 10.1016/S0006-8993(00)02441-0, 10924674.
30. Lynch JJ, Alexander KM, Jarvis MF, Kowaluk EA. Inhibition of adenosine kinase during oxygen-glucose deprivation in rat cortical neuronal cultures. Neurosci Lett 1998, 252:207-210. 10.1016/S0304-3940(98)00376-0, 9739997.
31. Parkinson FE, Xiong W. Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons. J Neurochem 2004, 88:1305-1312. 10.1046/j.1471-4159.2003.02266.x, 15009686.
32. Parkinson FE, Xiong W, Zamzow CR. Astrocytes and neurons: different roles in regulating adenosine levels. Neurol Res 2005, 27:153-160. 10.1179/016164105X21878, 15829178.
33. von Lubitz DK. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?. Eur J Pharmacol 1999, 371:85-102. 10.1016/S0014-2999(99)00135-1, 10355598.
34. Hasko G, Pacher P, Vizi ES, Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 2005, 26:511-516. 10.1016/j.tips.2005.08.004, 2228262, 16125796.
35. Ciccarelli R, Di Iorio P, Bruno V, Battaglia G, D'Alimonte I, D'Onofrio M, Nicoletti F, Caciagli F. Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes. Glia 1999, 27:275-281. 10.1002/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.0.CO;2-0, 10457374.
36. Fiebich BL, Biber K, Gyufko K, Berger M, Bauer J, van Calker D. Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J Neurochem 1996, 66:1426-1431.
37. Heese K, Fiebich BL, Bauer J, Otten U. Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors. Neurosci Lett 1997, 231:83-86. 10.1016/S0304-3940(97)00545-4, 9291146.
38. Schwaninger M, Neher M, Viegas E, Schneider A, Spranger M. Stimulation of interleukin-6 secretion and gene transcription in primary astrocytes by adenosine. J Neurochem 1997, 69:1145-1150.
39. Wittendorp MC, Boddeke HW, Biber K. Adenosine A3 receptor-induced CCL2 synthesis in cultured mouse astrocytes. Glia 2004, 46:410-418. 10.1002/glia.20016, 15095371.
40. Matos M, Augusto E, Oliveira CR, Agostinho P. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience 2008, 156:898-910. 10.1016/j.neuroscience.2008.08.022, 18790019.
41. Saura J. Microglial cells in astroglial cultures: a cautionary note. J Neuroinflammation 2007, 4:26. 10.1186/1742-2094-4-26, 2140055, 17937799.
42. Hamby ME, Uliasz TF, Hewett SJ, Hewett JA. Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes. J Neurosci Methods 2006, 150:128-137. 10.1016/j.jneumeth.2005.06.016, 16105687.
43. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
44. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63. 10.1016/0022-1759(83)90303-4, 6606682.
45. Feoktistov I, Biaggioni I. Adenosine A2B receptors. Pharmacol Rev 1997, 49:381-402.
46. Fredholm BB, Irenius E, Kull B, Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 2001, 61:443-448. 10.1016/S0006-2952(00)00570-0, 11226378.
47. Feng W, Song Y, Chen C, Lu ZZ, Zhang Y. Stimulation of adenosine A(2B) receptors induces interleukin-6 secretion in cardiac fibroblasts via the PKC-delta-P38 signalling pathway. Br J Pharmacol 2010, 159:1598-1607. 10.1111/j.1476-5381.2009.00558.x, 2925484, 20050850.
48. Fiebich BL, Akundi RS, Biber K, Hamke M, Schmidt C, Butcher RD, van Calker D, Willmroth F. IL-6 expression induced by adenosine A2b receptor stimulation in U373 MG cells depends on p38 mitogen activated kinase and protein kinase C. Neurochem Int 2005, 46:501-512. 10.1016/j.neuint.2004.11.009, 15769552.
49. Nagamoto-Combs K, Vaccariello SA, Zigmond RE. The levels of leukemia inhibitory factor mRNA in a Schwann cell line are regulated by multiple second messenger pathways. J Neurochem 1999, 72:1871-1881.
50. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol Cell Biol 1990, 10:2327-2334. 360580, 2183031.
51. Spooren A, Kooijman R, Lintermans B, Van Craenenbroeck K, Vermeulen L, Haegeman G, Gerlo S. Cooperation of NFκB and CREB to induce synergistic IL-6 expression in astrocytes. Cell Signal 2010, 22:871-881. 10.1016/j.cellsig.2010.01.018, 20100571.
52. Klausner RD, Donaldson JG, Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 1992, 116:1071-1080. 10.1083/jcb.116.5.1071, 2289364, 1740466.
53. Moller JC, Kruttgen A, Burmester R, Weis J, Oertel WH, Shooter EM. Release of interleukin-6 via the regulated secretory pathway in PC12 cells. Neurosci Lett 2006, 400:75-79. 10.1016/j.neulet.2006.02.018, 16503378.
54. Specht H, Peterziel H, Bajohrs M, Gerdes HH, Krieglstein K, Unsicker K. Transforming growth factor beta2 is released from PC12 cells via the regulated pathway of secretion. Mol Cell Neurosci 2003, 22:75-86. 10.1016/S1044-7431(02)00023-4, 12595240.
55. McPherson PS. Proteomic analysis of clathrin-coated vesicles. Proteomics 2010, 10:4025-4039. 10.1002/pmic.201000253, 21080493.
56. Deborde S, Perret E, Gravotta D, Deora A, Salvarezza S, Schreiner R, Rodriguez-Boulan E. Clathrin is a key regulator of basolateral polarity. Nature 2008, 452:719-723. 10.1038/nature06828, 18401403.
57. van Ijzendoorn SC, Mostov KE, Hoekstra D. Role of rab proteins in epithelial membrane traffic. Int Rev Cytol 2003, 232:59-88.
58. van Ijzendoorn SC. Recycling endosomes. J Cell Sci 2006, 119:1679-1681. 10.1242/jcs.02948, 16636069.
59. Aloisi F, Rosa S, Testa U, Bonsi P, Russo G, Peschle C, Levi G. Regulation of leukemia inhibitory factor synthesis in cultured human astrocytes. J Immunol 1994, 152:5022-5031.
60. Dallner C, Woods AG, Deller T, Kirsch M, Hofmann HD. CNTF and CNTF receptor alpha are constitutively expressed by astrocytes in the mouse brain. Glia 2002, 37:374-378. 10.1002/glia.10048, 11870876.
61. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461:282-286. 10.1038/nature08296, 2851546, 19741708.
62. Rees DA, Lewis BM, Lewis MD, Francis K, Scanlon MF, Ham J. Adenosine-induced IL-6 expression in pituitary folliculostellate cells is mediated via A2b adenosine receptors coupled to PKC and p38 MAPK. Br J Pharmacol 2003, 140:764-772. 10.1038/sj.bjp.0705488, 1574075, 14504137.
63. Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Blackburn MR, Biaggioni I, Feoktistov I. Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines. J Pharmacol Exp Ther 2008, 324:694-700.
64. Vazquez JF, Clement HW, Sommer O, Schulz E, van Calker D. Local stimulation of the adenosine A2B receptors induces an increased release of IL-6 in mouse striatum: an in vivo microdialysis study. J Neurochem 2008, 105:904-909. 10.1111/j.1471-4159.2007.05191.x, 18088370.
65. Kim MO, Kim MH, Lee SH, Suh HN, Lee YJ, Lee MY, Han HJ. 5'-N-ethylcarboxamide induces IL-6 expression via MAPKs and NF-κB activation through Akt, Ca(2+)/PKC, cAMP signaling pathways in mouse embryonic stem cells. J Cell Physiol 2009, 219:752-759. 10.1002/jcp.21721, 19194991.
66. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993, 90:10193-10197. 10.1073/pnas.90.21.10193, 47740, 8234276.
67. Stow JL, Low PC, Offenhauser C, Sangermani D. Cytokine secretion in macrophages and other cells: pathways and mediators. Immunobiology 2009, 214:601-612. 10.1016/j.imbio.2008.11.005, 19268389.
68. Huse M, Lillemeier BF, Kuhns MS, Chen DS, Davis MM. T cells use two directionally distinct pathways for cytokine secretion. Nat Immunol 2006, 7:247-255. 10.1038/ni1304, 16444260.
69. de Jong EK, Vinet J, Stanulovic VS, Meijer M, Wesseling E, Sjollema K, Boddeke HW, Biber K. Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles. FASEB J 2008, 22:4136-4145. 10.1096/fj.07-101907, 18697841.
70. Reefman E, Kay JG, Wood SM, Offenhauser C, Brown DL, Roy S, Stanley AC, Low PC, Manderson AP, Stow JL. Cytokine secretion is distinct from secretion of cytotoxic granules in NK cells. J Immunol 2010, 184:4852-4862. 10.4049/jimmunol.0803954, 20368273.
71. Manderson AP, Kay JG, Hammond LA, Brown DL, Stow JL. Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNFalpha. J Cell Biol 2007, 178:57-69. 10.1083/jcb.200612131, 2064421, 17606866.
72. Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009, 10:148-155. 10.1038/nrm2617, 19122676.
73. Cheema SS, Richards LJ, Murphy M, Bartlett PF. Leukaemia inhibitory factor rescues motoneurones from axotomy-induced cell death. Neuroreport 1994, 5:989-992. 10.1097/00001756-199404000-00034, 8061310.
74. Tham S, Dowsing B, Finkelstein D, Donato R, Cheema SS, Bartlett PF, Morrison WA. Leukemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle. J Neurosci Res 1997, 47:208-215. 10.1002/(SICI)1097-4547(19970115)47:2<208::AID-JNR9>3.0.CO;2-J, 9008151.
75. Nakagawa T, Schwartz JP. Expression of neurotrophic factors and cytokines and their receptors on astrocytesin vivo.In Advances in Molecular and Cell Biology: Non-Neuronal Cells of the Nervous System: Function and Dysfunction Volume 31 2003, 561-573. Elsevier, Amsterdam.
76. Gribkoff VK, Bauman LA. Endogenous adenosine contributes to hypoxic synaptic depression in hippocampus from young and aged rats. J Neurophysiol 1992, 68:620-628.
77. Fowler JC. Purine release and inhibition of synaptic transmission during hypoxia and hypoglycemia in rat hippocampal slices. Neurosci Lett 1993, 157:83-86. 10.1016/0304-3940(93)90648-5, 8233037.
78. Lloyd HG, Lindstrom K, Fredholm BB. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem Int 1993, 23:173-185. 10.1016/0197-0186(93)90095-M, 8369741.
79. Latini S, Bordoni F, Corradetti R, Pepeu G, Pedata F. Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol 1999, 128:1035-1044. 10.1038/sj.bjp.0702888, 1571729, 10556941.
80. Arvin B, Neville LF, Pan J, Roberts PJ. 2-chloroadenosine attenuates kainic acid-induced toxicity within the rat straitum: relationship to release of glutamate and Ca2+ influx. Br J Pharmacol 1989, 98:225-235. 10.1111/j.1476-5381.1989.tb16886.x, 1854680, 2804547.
81. Lloyd HG, Perkins A, Spence I. Effect of magnesium on depression of the monosynaptic reflex induced by 2-chloroadenosine or hypoxia in the isolated spinal cord of neonatal rats. Neurosci Lett 1989, 101:175-181. 10.1016/0304-3940(89)90526-0, 2549460.
82. Pingle SC, Jajoo S, Mukherjea D, Sniderhan LF, Jhaveri KA, Marcuzzi A, Rybak LP, Maggirwar SB, Ramkumar V. Activation of the adenosine A1 receptor inhibits HIV-1 tat-induced apoptosis by reducing nuclear factor-kappaB activation and inducible nitric-oxide synthase. Mol Pharmacol 2007, 72:856-867. 10.1124/mol.106.031427, 17609415.
83. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001, 24:31-55. 10.1146/annurev.neuro.24.1.31, 11283304.
84. Ramkumar V, Hallam DM, Nie Z. Adenosine, oxidative stress and cytoprotection. Jpn J Pharmacol 2001, 86:265-274. 10.1254/jjp.86.265, 11488425.
85. Kuno A, Critz SD, Cui L, Solodushko V, Yang XM, Krahn T, Albrecht B, Philipp S, Cohen MV, Downey JM. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J Mol Cell Cardiol 2007, 43:262-271. 10.1016/j.yjmcc.2007.05.016, 2729547, 17632123.
86. Rosi S, McGann K, Hauss-Wegrzyniak B, Wenk GL. The influence of brain inflammation upon neuronal adenosine A2B receptors. J Neurochem 2003, 86:220-227.
87. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, et al. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 2006, 116:1913-1923. 10.1172/JCI27933, 1483170, 16823489.